Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Allergic Reactions to SARS-CoV-2 Vaccination

NCT04761822 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT04761822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04761822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Allergic Reactions to SARS-CoV-2 Vaccination
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 2
Overall status
Completed
Start date
April 7, 2021
Completion date
April 27, 2022
Enrollment
746 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

allergic reaction, covid-19, mast cell disorder, sars-cov infection